Elena Baron-Alvarez

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depression.

AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depression.

Journal: BMJ neurology open

Published: December 22, 2025

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment.

Journal: Epilepsy & behavior : E&B

Published: December 19, 2025

Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial.

Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial.

Journal: European journal of neurology

Published: December 19, 2025

Management of schizophrenia patients in acute setting - a multinational survey of prescription patterns in five European countries.

Management of schizophrenia patients in acute setting - a multinational survey of prescription patterns in five European countries.

Journal: International journal of psychiatry in clinical practice

Published: December 14, 2025

Perspectives on the burden of drug-resistant epilepsy and treatment priorities: Findings from a multistakeholder survey.

Perspectives on the burden of drug-resistant epilepsy and treatment priorities: Findings from a multistakeholder survey.

Journal: Epilepsia open

Published: October 28, 2025

Healthcare resource utilization in adults with focal onset seizures before and after initiating cenobamate: A US database analysis.

Healthcare resource utilization in adults with focal onset seizures before and after initiating cenobamate: A US database analysis.

Journal: Epilepsy research

Published: September 30, 2025

Seizures beget more than seizures: Understanding the cellular, structural, individual and societal impact of seizures in epilepsy.

Seizures beget more than seizures: Understanding the cellular, structural, individual and societal impact of seizures in epilepsy.

Journal: Epilepsia open

Published: May 29, 2025

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.

Journal: Patient preference and adherence

Published: October 23, 2024

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence.

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence.

Journal: Frontiers in psychiatry

Published: October 04, 2024

The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults.

The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults.

Journal: International clinical psychopharmacology

Published: July 25, 2024

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).

Journal: Epilepsy & behavior : E&B

Published: April 27, 2023

Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.

Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.

Journal: Epilepsy & behavior : E&B

Published: October 17, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026